SCHEMBL19627182

SCHEMBL19627182

Cc1cc2occ(CCBr)c2cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.56
▸ KMT2A Q03164 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MTNR1A P48039 3/20 0.38
▸ AIMP2 Q13155 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KCNA2 P16389 1/20 0.34
▸ KCNA1 Q09470 1/20 0.34
▸ HTR1A P08908 2/20 0.33
▸ HTR1D P28221 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ NQO2 P16083 1/20 0.32
▸ MTNR1B P49286 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19627159 0.86 ALOX15 (0.43) ALOX15KMT2AALDH1A1KDM4EPOLB
SCHEMBL17785109 0.84 MTNR1A (0.56) ALOX15ALDH1A1KDM4EPOLBHPGD
SCHEMBL19627181 0.81 ALOX15 (0.60) ALOX15KMT2AALDH1A1KDM4EPOLB
SCHEMBL19627152 0.79 THRB (0.47) ALOX15ALDH1A1POLBTSHRMTNR1A
SCHEMBL9972450 0.76 ALOX15 (0.47) ALOX15KMT2AALDH1A1KDM4EPOLB
SCHEMBL17785128 0.73 MTNR1A (0.40) KMT2AKDM4EPOLBHPGDMTNR1A
SCHEMBL6213614 0.71 HTR6 (0.45) KDM4EMTNR1AHTR1AHTR1DHTR2C
SCHEMBL11186988 0.71 AHR (0.37) ALOX15ALDH1A1HSD17B10MAPTSMN1; SMN2
SCHEMBL4945911 0.71 PIM1 (0.51) ALOX15KMT2AALDH1A1KDM4EPOLB
SCHEMBL6217970 0.71 MTNR1A (0.64) ALDH1A1TSHRMTNR1AHTR2CNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840541-B2 Opioid receptor modulators THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-12-12 — — US disclosed
US-20230271976-A1 OPIOID RECEPTOR MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-08-31 — — US disclosed
US-20170334923-A1 OPIOID RECEPTOR MODULATORS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-11-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334923-A1 OPIOID RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 ALOX15 804/4885KMT2A 1649/4885ALDH1A1 2434/4885
US-20230271976-A1 OPIOID RECEPTOR MODULATORS OPRM1, OPRL1, OPRD1 ALOX15 916/4885KMT2A 1891/4885ALDH1A1 2316/4885
US-11840541-B2 Opioid receptor modulators OPRM1, OPRL1, OPRD1 ALOX15 804/4885KMT2A 1649/4885ALDH1A1 2434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback